Purpura: all 45 studies
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Finerenone Therapy for Pediatric HSPN With Mild ProteinuriaRecruitingNCT07315191Phase 4
- A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune ThrombocytopeniaRecruitingNCT07017725Phase 1/2
- A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06948318Phase 3
- A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06722235Phase 3
- S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary AmyloidosisCompletedNCT03499808Phase 2Results posted
- Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)CompletedNCT01963260Phase 1Results posted
- Study to Assess DerMend Moisturizing Bruise Formula in Improving the Appearance of Chronically Aged Forearms and HandsCompletedNCT01910831Phase 4Results posted
- Eltrombopag Phase III Study In Chinese Chronic ITP PatientsCompletedNCT01762761Phase 3Results posted
- A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT01098487Phase 4Results posted
- Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00908037Phase 2Results posted
- Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)CompletedNCT00424177Phase 2Results posted
- RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With EltrombopagCompletedNCT00370331Phase 3Results posted
- EXTEND (Eltrombopag Extended Dosing Study)CompletedNCT00351468Phase 3Results posted
- Evaluation of Tretinoin Cream on the Integrity of Aged Forearm SkinCompletedNCT07084116Phase 2/3
- The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)WithdrawnNCT06291415Phase 1
- Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura.CompletedNCT06288932Phase 3
- Prevalence and Comorbidities of Dermatoporosis: a French Prospective Observational Study in General Medicine ConsultationCompletedNCT05699980
- Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP PatientsCompletedNCT05492409Phase 3
- Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITPCompletedNCT05220878Phase 3
- Factors Associated With DermatoporosisCompletedNCT05037604
- Microneedling for DermatoporosisStatus unknownNCT04912219Not applicable
- Study on the Treatment of Children With Purpura Nephritis With Huaiqihuang GranulesStatus unknownNCT04623866Early Phase 1
- Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep TreatmentStatus unknownNCT03591471Phase 1/2
- Investigation on a Dynamic Cohort of Italian Patients With Active ITPStatus unknownNCT03465020
- The Study of Different Dose Rituximab in the Treatment of ITPCompletedNCT03258866Phase 4
- Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITPStatus unknownNCT03252457Phase 3
- Tacrolimus in Children With Henoch-Schönlein Purpura NephritisCompletedNCT03222687Phase 4
- ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITPCompletedNCT01971684
- All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)WithdrawnNCT01882127Phase 3
- Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)WithdrawnNCT01734057Phase 3
- rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITPCompletedNCT01734044Phase 3
- rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITPCompletedNCT01525836Phase 3
- Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)CompletedNCT01506414Phase 3
- A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile PurpuraStatus unknownNCT01485367Phase 2
- A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.WithdrawnNCT01440361Phase 2
- Drug Use Investigation for REVOLADE (ITP)CompletedNCT01416311
- A Novel Oral Natural Extract for the Treatment of Senile PurpuraStatus unknownNCT01183910Not applicable
- Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food EffectCompletedNCT01072162Phase 1
- Promacta Pregnancy RegistryCompletedNCT01064336
- Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of EltrombopagCompletedNCT00688272Phase 1
- LENS - Long-term Eltrombopag Observational StudyCompletedNCT00643929
- Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal ImpairmentCompletedNCT00442871Phase 1
- Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic ImpairmentCompletedNCT00359463Phase 1
- Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged SkinCompletedNCT00272610Phase 2
- SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)CompletedNCT00102739Phase 2